NM_001167.4(XIAP):c.1021_1022del (p.Asn341fs)Pathogenic
X-linked lymphoproliferative disease due to XIAP deficiency|not provided
β
β
ββ2025β Residue 341
NM_001167.4(XIAP):c.664C>T (p.Arg222Ter)Pathogenic
X-linked lymphoproliferative disease due to XIAP deficiency|Nonpapillary renal cell carcinoma|Inborn genetic diseases
β
β
ββ2025β Residue 222
NM_001167.4(XIAP):c.389_392del (p.Asp130fs)Pathogenic
X-linked lymphoproliferative disease due to XIAP deficiency|Inborn genetic diseases
β
β
ββ2025β Residue 130
NM_001167.4(XIAP):c.894_898del (p.Lys299fs)Pathogenic
not provided|X-linked lymphoproliferative disease due to XIAP deficiency
β
β
ββ2025β Residue 299
NM_001167.4(XIAP):c.609TGG[1] (p.Gly205del)Pathogenic
X-linked lymphoproliferative disease due to XIAP deficiency|not provided
β
β
ββ2025β Residue 205
NM_001167.4(XIAP):c.1141C>T (p.Arg381Ter)Pathogenic
Recurrent infections;Sepsis|not provided|X-linked lymphoproliferative disease due to XIAP deficiency
β
β
ββ2025β Residue 381
NM_001167.4(XIAP):c.345C>G (p.Tyr115Ter)Pathogenic
not provided|X-linked lymphoproliferative disease due to XIAP deficiency
β
β
ββ2024β Residue 115
NM_001167.4(XIAP):c.108del (p.Pro37fs)Pathogenic
not provided|X-linked lymphoproliferative disease due to XIAP deficiency
β
β
ββ2024β Residue 37
NM_001167.4(XIAP):c.985del (p.Tyr329fs)Pathogenic
X-linked lymphoproliferative disease due to XIAP deficiency
β
β
ββ2023β Residue 329
NM_001167.4(XIAP):c.1009G>T (p.Glu337Ter)Pathogenic
X-linked lymphoproliferative disease due to XIAP deficiency|XIAP-related disorder
β
β
ββ2023β Residue 337
NM_001167.4(XIAP):c.1481T>A (p.Ile494Asn)Likely pathogenic
X-linked lymphoproliferative disease due to XIAP deficiency
β
βββ2026β Residue 494
NM_001167.4(XIAP):c.631G>T (p.Glu211Ter)Pathogenic
X-linked lymphoproliferative disease due to XIAP deficiency
β
βββ2025β Residue 211
NM_001167.4(XIAP):c.1114C>T (p.Gln372Ter)Pathogenic
X-linked lymphoproliferative disease due to XIAP deficiency
β
βββ2025β Residue 372
NM_001167.4(XIAP):c.568dup (p.Tyr190fs)Pathogenic
X-linked lymphoproliferative disease due to XIAP deficiency
β
βββ2025β Residue 190
NM_001167.4(XIAP):c.518G>A (p.Trp173Ter)Pathogenic
X-linked lymphoproliferative disease due to XIAP deficiency
β
βββ2025β Residue 173
NM_001167.4(XIAP):c.449C>G (p.Ser150Ter)Pathogenic
X-linked sideroblastic anemia 1
β
βββ2025β Residue 150
NM_001167.4(XIAP):c.1038_1041dup (p.Leu348fs)Pathogenic
X-linked lymphoproliferative disease due to XIAP deficiency
β
βββ2025β Residue 348
NM_001167.4(XIAP):c.1386del (p.Phe462fs)Pathogenic
X-linked lymphoproliferative disease due to XIAP deficiency
β
βββ2025β Residue 462
NM_001167.4(XIAP):c.134C>G (p.Ser45Ter)Pathogenic
X-linked lymphoproliferative disease due to XIAP deficiency
β
βββ2025β Residue 45
NM_001167.4(XIAP):c.1087dup (p.Thr363fs)Pathogenic
X-linked lymphoproliferative disease due to XIAP deficiency
β
βββ2025β Residue 363